Therefore, extensive validation of this marker on a larger number of samples, including those from patients suffering from other diseases and infections (HIV, herpes, bacterial vaginosis, Chlamydia etc.), is the next step to determine whether ACTN4 is suitable for diagnosis purposes. This evidence concerns the gene ACTN4 and bacterial vaginosis.